Dare Bioscience/$DARE
About Dare Bioscience
Ticker
Industry
Employees
Dare Bioscience Metrics
$29M
-
-$0.43
1.34
-
Price and volume
Market cap
$29M
Beta
1.34
52-week high
$7.56
52-week low
$2.67
Average daily volume
50K
Financial strength
Current ratio
1.136
Quick ratio
0.893
Long term debt to equity
-362.925
Total debt to equity
-396.999
Management effectiveness
Return on assets (TTM)
-66.79%
Return on equity (TTM)
191.07%
Valuation
Price to revenue (TTM)
14.765
Price to book
-19.23
Price to tangible book (TTM)
-19.23
Price to free cash flow (TTM)
-3.219
Growth
Revenue change (TTM)
88.13%
Earnings per share change (TTM)
-92.44%
3-year earnings per share growth (CAGR)
-61.85%
What the Analysts think about Dare Bioscience
Analyst Ratings
Dare Bioscience Financial Performance
Income Statement
Q3 24
QoQ growth
$37B
-39.75%
$45B
107.52%
37.65%
6.78%
Dare Bioscience Earnings Performance
Earnings per share (EPS)
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
$3.69
$2.85
$2.45
$2.42
-
$3.55
$2.61
$2.05
$2.31
$3.94
3.94%
9.20%
19.51%
4.63%
-
Dare Bioscience News
Daré Bioscience to Participate in the Women's Health Series at the 43rd Annual J.P. Morgan Healthcare Conference
Daré Bioscience, Inc. (DARE) Q3 2024 Earnings Call Transcript
Daré Bioscience Reports Third Quarter 2024 Financial Results and Provides Company Update
FAQs
What’s the current market cap for Dare Bioscience stock?
What is the P/E ratio for Dare Bioscience stock?
Does Dare Bioscience stock pay dividends?
No, Dare Bioscience (DARE) stock does not pay dividends to its shareholders as of January 15, 2025.
When is the next Dare Bioscience dividend payment date?
Dare Bioscience (DARE) stock does not pay dividends to its shareholders.
What is the beta indicator for Dare Bioscience?
Dare Bioscience (DARE) has a beta rating of 1.34. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.